Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7341744 | NAPO PHARMS INC | Method of treating secretory diarrhea with enteric formulations of proanthocyanidin polymer |
Jun, 2022
(9 months ago) | |
US9585868 | NAPO PHARMS INC | Methods and compositions for treating HIV-associated diarrhea |
Oct, 2031
(8 years from now) | |
US8962680 | NAPO PHARMS INC | Methods and compositions for treating HIV-associated diarrhea |
Oct, 2031
(8 years from now) |
Market Authorisation Date: 31 December, 2012
Treatment: Symptomatic relief of non-infectious diarrhea
Dosage: TABLET, DELAYED RELEASE;ORAL
9
United States
2
China
2
Japan
1
Portugal
1
Russia
1
Spain
1
Brazil
1
Colombia
1
Mexico
1
Peru
1
Hong Kong
1
South Africa
1
Canada
1
Hungary
1
Ukraine
1
Poland
1
Australia
1
Ecuador
1
Denmark
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic